Pharming Group's market cap is currently $619.89M. The company's EPS TTM is $-0.258; its P/E ratio is ―; Pharming Group is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 245.32M	€ 205.62M	€ 189.85M	€ 228.39M	€ 189.33M
Gross Profit	€ 220.10M	€ 188.06M	€ 169.67M	€ 203.06M	€ 165.41M
Operating Income	€ -4.88M	€ 18.23M	€ 27.84M	€ 82.09M	€ 68.23M
EBITDA	€ 9.88M	€ 33.53M	€ 48.78M	€ 92.11M	€ 71.46M
Net Income	€ -10.55M	€ 13.67M	€ 16.00M	€ 37.75M	€ 40.54M
Balance Sheet
Cash & Short-Term Investments	€ 213.42M	€ 207.34M	€ 191.72M	€ 205.49M	€ 74.27M
Total Assets	€ 462.85M	€ 425.80M	€ 396.90M	€ 419.12M	€ 255.63M
Total Debt	€ 171.54M	€ 166.69M	€ 161.59M	€ 162.22M	€ 58.14M
Net Debt	€ 109.80M	€ -40.65M	€ -30.13M	€ -43.27M	€ -16.13M
Total Liabilities	€ 244.07M	€ 221.16M	€ 204.19M	€ 235.39M	€ 138.38M
Stockholders' Equity	€ 218.78M	€ 204.64M	€ 192.72M	€ 183.73M	€ 117.26M
Cash Flow
Free Cash Flow	€ -18.77M	€ 20.92M	€ 20.17M	€ 74.51M	€ 49.11M
Operating Cash Flow	€ -17.30M	€ 22.90M	€ 36.13M	€ 90.98M	€ 74.56M
Investing Cash Flow	€ -129.39M	€ 5.32M	-	-	-
Financing Cash Flow	€ -1.04M	€ -4.98M	-	€ 65.33M	-

Currency in EUR

Pharming Group Earnings and Revenue History

Income Statement >

Pharming Group Debt to Assets

Balance Sheet >

Pharming Group Cash Flow

Cash Flow >

Pharming Group Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing